94 related articles for article (PubMed ID: 12202968)
1. Effects of selegiline (L-deprenyl) during smoking and short-term abstinence.
Houtsmuller EJ; Thornton JA; Stitzer ML
Psychopharmacology (Berl); 2002 Sep; 163(2):213-20. PubMed ID: 12202968
[TBL] [Abstract][Full Text] [Related]
2. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
3. Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking relapse.
al'Absi M; Hatsukami D; Davis GL; Wittmers LE
Drug Alcohol Depend; 2004 Mar; 73(3):267-78. PubMed ID: 15036549
[TBL] [Abstract][Full Text] [Related]
4. Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms.
Rose JE; Behm FM; Ramsey C; Ritchie JC
Nicotine Tob Res; 2001 Nov; 3(4):383-90. PubMed ID: 11694206
[TBL] [Abstract][Full Text] [Related]
5. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
Le Houezec J; Säwe U
J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
[TBL] [Abstract][Full Text] [Related]
6. Acute doses of d-amphetamine and bupropion increase cigarette smoking.
Cousins MS; Stamat HM; de Wit H
Psychopharmacology (Berl); 2001 Sep; 157(3):243-53. PubMed ID: 11605079
[TBL] [Abstract][Full Text] [Related]
7. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.
Weinberger AH; Reutenauer EL; Jatlow PI; O'Malley SS; Potenza MN; George TP
Drug Alcohol Depend; 2010 Mar; 107(2-3):188-95. PubMed ID: 19939587
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoamine oxidase B in the brains of smokers.
Fowler JS; Volkow ND; Wang GJ; Pappas N; Logan J; MacGregor R; Alexoff D; Shea C; Schlyer D; Wolf AP; Warner D; Zezulkova I; Cilento R
Nature; 1996 Feb; 379(6567):733-6. PubMed ID: 8602220
[TBL] [Abstract][Full Text] [Related]
10. Evidence for reduced arterial plasma input, prolonged lung retention and reduced lung monoamine oxidase in smokers.
Logan J; Fowler JS
Nucl Med Biol; 2005 Jul; 32(5):521-9. PubMed ID: 15982583
[TBL] [Abstract][Full Text] [Related]
11. Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy.
Killen JD; Fortmann SP; Murphy GM; Hayward C; Fong D; Lowenthal K; Bryson SW; Killen DT; Schatzberg AF
Addiction; 2010 Sep; 105(9):1660-8. PubMed ID: 20707784
[TBL] [Abstract][Full Text] [Related]
12. (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties.
Magyar K; Szende B
Neurotoxicology; 2004 Jan; 25(1-2):233-42. PubMed ID: 14697898
[TBL] [Abstract][Full Text] [Related]
13. Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes.
Buchhalter AR; Acosta MC; Evans SE; Breland AB; Eissenberg T
Addiction; 2005 Apr; 100(4):550-9. PubMed ID: 15784070
[TBL] [Abstract][Full Text] [Related]
14. Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region.
Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Ameli N; Schatzberg AF; Murphy GM
Nicotine Tob Res; 2015 Sep; 17(9):1126-33. PubMed ID: 25572450
[TBL] [Abstract][Full Text] [Related]
15. Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence.
Gilbert DG; Zuo Y; Browning RA; Shaw TM; Rabinovich NE; Gilbert-Johnson AM; Plath L
Nicotine Tob Res; 2003 Dec; 5(6):813-9. PubMed ID: 14668065
[TBL] [Abstract][Full Text] [Related]
16. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
18. Pre-quit depression level and smoking expectancies for mood management predict the nature of smoking withdrawal symptoms in college women smokers.
Copeland AL; Kulesza M; Hecht GS
Addict Behav; 2009 May; 34(5):481-3. PubMed ID: 19157715
[TBL] [Abstract][Full Text] [Related]
19. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction.
Thornley S; McRobbie H; Lin RB; Bullen C; Hajek P; Laugesen M; Senior H; Whittaker R
Nicotine Tob Res; 2009 Jun; 11(6):715-21. PubMed ID: 19454549
[TBL] [Abstract][Full Text] [Related]
20. An experimental test of the influence of prior cigarette smoking abstinence on future abstinence.
Heil SH; Alessi SM; Lussier JP; Badger GJ; Higgins ST
Nicotine Tob Res; 2004 Jun; 6(3):471-9. PubMed ID: 15203781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
